Examination of Firearms Review: 2007 to 2010 - Interpol

156 Ewald AH, Ehlers D, Maurer HH. Metabolism and toxicological detection
of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine
using gas chromatography-mass spectrometry. Analytical & Bioanalytical
Chemistry 2008 Apr; 390(7): 1837-1842.
157 Meyer MR, Wilhelm J, Peters FT, Maurer HH. Beta-keto amphetamines:
Studies on the metabolism of the designer drug mephedrone and
toxicological detection of mephedrone, butylone, and methylone in urine
using gas chromatography-mass spectrometry. Analytical & Bioanalytical
Chemistry 2010 Jun; 397 (3): 1225-1233.
158 Andreasen MR, Telving R, Birkler RI, Schumacher B, Johannsen M. A
fatal poisoning involving Bromo-Dragonfly. Forensic Science International
2009 Jan; 188 (1-3): 91-96.
159 Zaitsu K, Katagi M, Kamata T, Kamata H, Shima N, Tsuchihashi H, et al.
Determination of a newly encountered designer drug
“p-methoxyethylamphetamine” and its metabolites in human urine and
blood. Forensic Science International 2008 May; 177 (1-2): 77-84.
160 Archer RP. Fluoromethcathinone, a new substance of abuse. Forensic
Science International 2009 Mar; 185 (1-3): 10-20.
161 In Legislation Bills of New Zealand: Misuse of Drugs (Classification of
BZP) Amendment Act 2008 (08/5).
http://www.parliament.nz/en-NZ/PB/Legislation/Bills/d/3/d/00DBHOH_BIL
L8220_1-Misuse-of-Drugs-Classification-of-BZP-Amendment.htm. 2008
March.
162 Johnstone AC, Lea RA, Brennan KA, Schenk S, Kennedy MA,
Fitzmaurice PS. Benzylpiperazine: A drug of abuse? Journal of
Psychopharmacoloy 2007 Nov; 21 (8): 888-894.
163 Brennan KA, Lake B, Hely LS, Jones K, Gittings D, Colussi-Mas J, et al.
N-benzylpiperazine has characteristics of a drug of abuse. Behavioural
Pharmacology 2007 Dec; 18 (8): 785-790.
164 Wilkins C, Sweetsur P, Girling M. Patterns of
benzylpiperazine/trifluoromethylphenylpiperazine party pill use and
adverse effects in a population sample in New Zealand. Drug and Alcohol
Review 2008 Nov; 27 (6): 633-639.
165 Lecompte Y, Roussel O, Perrin M. 1-Benzylpiperazine (BZP) and
1-(3-trifluoromethylphenyl)piperazine (TFMPP): Emergence of two agents
which lead to misuse. Annales Pharmaceutiques Françaises 2008 Mar;
66 (2): 85-91.
166 Wood DM, Button J, Lidder S, Ramsey J, Holt DW, Dargan PI.
Dissociative and sympathomimetic toxicity associated with recreational
use of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and
1-benzylpiperazine (BZP). Journal of Medical Toxicology 2008 Dec; 4(4):
254-257.
701